LOX and ovarian carcinoma: High mRNA expression of Col1a1, Col1a2, FN1 and LOX was linked to a poor prognosis in ovarian cancer, as shown by the reduced overall survival (OS) and progression free survival (PFS) (http://kmplot.com) (Fig. 1b, c).